Deborah M. Messemer, Director at Allogene Therapeutics, Inc. (ALLO), sold 13,313 shares at $2.43 ($32K) on 2025-02-18, disclosed to the SEC on 2025-02-20.
Scheduled sale ($32k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PYPL | SELL | 2025-06-06 | $277K | — | Filing → |
| TPG | SELL | 2025-01-15 | $210K | — | Filing → |
| ALLO | SELL | 2024-12-10 | $20K | — | Filing → |